NCT01689324View on ClinicalTrials.gov

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

May 31, 2013

Conditions
PertussisTetanusDiphtheria
Interventions
BIOLOGICAL

(ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis

0.5 mL, Intramuscular

Trial Locations (3)

Unknown

Aichi

Ibaraki

Nagano

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01689324 - Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents | Biotech Hunter | Biotech Hunter